Legalising cannabis will actually decrease company value significantly. Too much competition. It will be a diluted market with plenty companies to choose from. Imo will be medical claims which generate higher value than recreational as any company can supply recreational weed.. This company is just one fish in a big pond. Doing well atm though. But too much uncertainty for me now
Ann: Changes to clinical operations, page-26
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
